HALB HALB

Halberd (PK) Stock Price

0.014
0.00113 (8.78%)
0.014
Volume 460,165
Bid Price 0.0126
Ask Price 0.014
News -
Day High 0.014

Low
0.0092

52 Week Range

High
0.046

Day Low 0.0125
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Halberd Corp (PK) HALB OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00113 8.78% 0.014 15:52:20
Open Price Low Price High Price Close Price Prev Close
0.01285 0.0125 0.014 0.014 0.01287
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
20 460,165 $ 0.013166 $ 6,058 - 0.0092 - 0.046
Last Trade Time Type Quantity Stock Price Currency
15:31:57 3,000 $ 0.014 USD

Period:

Draw Mode:

Halberd Corp (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.16M 511.62M 280.54M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.74k $ - - - -

more financials information »

Halberd (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HALB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.012650.0150.0117980.01268021,910,3220.0013510.67%
1 Month0.01450.01870.010.01413582,369,125-0.0005-3.45%
3 Months0.01690.01930.00920.01505321,634,423-0.0029-17.16%
6 Months0.02390.02810.00920.01772781,513,560-0.0099-41.42%
1 Year0.0290.0460.00920.02551232,721,658-0.015-51.72%
3 Years0.00090.1090.00040.03137047,404,1430.01311,455.56%
5 Years0.00070.1090.00040.02968556,002,6630.01331,900.0%

Halberd (PK) Description

Halberd Corporation is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases Our patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing. To treat the specific disease, the appropriate treatment process is applied to the fluid. This can include exposure to radio frequency or laser irradiation or chemical bonding to kill or trap the target disease antigens. The cleansed fluid is then returned to the patient.


Your Recent History
USOTC
HALB
Halberd (P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now